DCUAX
Price
$12.49
Change
-$0.04 (-0.32%)
Updated
Apr 15 closing price
Net Assets
597.57M
RMEBX
Price
$53.58
Change
-$0.19 (-0.35%)
Updated
Apr 15 closing price
Net Assets
98.11B
Ad is loading...

DCUAX vs RMEBX

Header iconDCUAX vs RMEBX Comparison
Open Charts DCUAX vs RMEBXBanner chart's image
DWS CROCI US A
Price$12.49
Change-$0.04 (-0.32%)
VolumeN/A
Net Assets597.57M
American Funds American Mutual R2E
Price$53.58
Change-$0.19 (-0.35%)
VolumeN/A
Net Assets98.11B
DCUAX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCUAX vs. RMEBX commentary
Apr 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCUAX is a StrongBuy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 98.1B vs. DCUAX (598M). DCUAX (1.20) and RMEBX (1.18) have matching dividends . DCUAX was incepted earlier than RMEBX: DCUAX (10 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than DCUAX (1.00). DCUAX is a more actively managed with annual turnover of: 61.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than DCUAX: RMEBX (250) vs DCUAX (1000). RMEBX annual gain was more profitable for investors over the last year : 4.42 vs. DCUAX (-7.29). DCUAX (55.34) and RMEBX (53.54) have equivalent 5 years return.
DCUAXRMEBXDCUAX / RMEBX
Total Expense Ratio1.001.0793%
Annual Report Gross Expense Ratio1.001.0793%
Fund Existence10 years11 years-
Gain YTD-9.856-2.139461%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets598M98.1B1%
Annual Yield % from dividends1.201.18101%
Returns for 1 year-7.294.42-165%
Returns for 3 years6.516.45101%
Returns for 5 years55.3453.54103%
Returns for 10 years41.1955.0075%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WBS44.360.92
+2.12%
Webster Financial Corp
URGN10.750.15
+1.42%
UroGen Pharma Ltd
PNFPP24.270.22
+0.92%
Pinnacle Financial Partners
STR15.550.09
+0.58%
Sitio Royalties Corp
GALT1.34N/A
N/A
Galectin Therapeutics